Biogen (BIIB) Analyst & Key Data

Analyst Consensus

Buy57 analysts

Buy

Updated Sep 12, 2026

Total Analysts57

Buy

31

Hold

17

Sell

1

Ratings

Updated Sep 12, 2026

Overall Rating

B+

DCF Score5.0 / 5

Debt / Equity Score2.0 / 5

Price / Book Score3.0 / 5

Price / Earnings Score1.0 / 5

ROA Score4.0 / 5

ROE Score3.0 / 5

Valuation

Current Stock Price

$217.15

Median Target-0.69%

$215.65

Potential downside vs current price

DCF Value+157.21%

$558.52

Potential upside vs current price

Current Stock Price

$217.15

Median Target-0.69%

$215.65

Potential downside vs current price

DCF Value+157.21%

$558.52

Potential upside vs current price

Analyst Consensus

Buy57 analysts

Buy

Updated Sep 12, 2026

Total Analysts57

Buy

31

Hold

17

Sell

1

Ratings

Updated Sep 12, 2026

Overall Rating

B+

DCF Score5.0 / 5

Debt / Equity Score2.0 / 5

Price / Book Score3.0 / 5

Price / Earnings Score1.0 / 5

ROA Score4.0 / 5

ROE Score3.0 / 5

Valuation

Current Stock Price

$217.15

Median Target-0.69%

$215.65

Potential downside vs current price

DCF Value+157.21%

$558.52

Potential upside vs current price

Current Stock Price

$217.15

Median Target-0.69%

$215.65

Potential downside vs current price

DCF Value+157.21%

$558.52

Potential upside vs current price

Biogen Inc.